Moreover, RIPK3-phosphorylated TRIM28 could upregulate NF-κB in tumor cells, leading to elevated immunostimulatory cytokine such as GM-CSF expression, thereby contributing to robust cytotoxic anti-tumor immunity [56]. Here, TRIM28 is linked to neoplasm.